PE20080338A1 - 4-[5-(2-amino-etansulfonil)-isoquinolin-7-il]-fenol como inhibidor de akt (proteina cinasa) - Google Patents
4-[5-(2-amino-etansulfonil)-isoquinolin-7-il]-fenol como inhibidor de akt (proteina cinasa)Info
- Publication number
- PE20080338A1 PE20080338A1 PE2007000768A PE2007000768A PE20080338A1 PE 20080338 A1 PE20080338 A1 PE 20080338A1 PE 2007000768 A PE2007000768 A PE 2007000768A PE 2007000768 A PE2007000768 A PE 2007000768A PE 20080338 A1 PE20080338 A1 PE 20080338A1
- Authority
- PE
- Peru
- Prior art keywords
- etansulfonil
- isoquinolin
- phenol
- amino
- akt
- Prior art date
Links
- 102000001253 Protein Kinase Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 108060006633 protein kinase Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000034578 Multiple myelomas Diseases 0.000 abstract 1
- 206010029260 Neuroblastoma Diseases 0.000 abstract 1
- 206010035226 Plasma cell myeloma Diseases 0.000 abstract 1
- 239000003125 aqueous solvent Substances 0.000 abstract 1
- 210000004696 endometrium Anatomy 0.000 abstract 1
- 208000005017 glioblastoma Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 210000001685 thyroid gland Anatomy 0.000 abstract 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE AL COMPUESTO 4-[5-(2-AMINO-ETANSULFONIL)-ISOQUINOLIN-7-IL]-FENOL EN LA FORMA DE DICLORHIDRATO O SEMI-HIDRATO MONOCLORHIDRATO. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA JUNTO A EXCIPIENTES FARMACEUTICAMENTE ACEPTABLES, EN DONDE EL pH DE DICHA COMPOSICION, CUANDO SE DILUYE CON UN SOLVENTE ACUOSO, ES MENOS DE 4.2 Y MAYOR DE 2.0. DICHO COMPUESTO ES UTIL EN EL TRATAMIENTO DE MIELOMA MULTIPLE, CANCER DE PULMON DE CELULAS NO PEQUENAS, GLIOBLASTOMA, NEUROBLASTOMA, ENDOMETRIO, TIROIDES, ENTRE OTROS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80526006P | 2006-06-20 | 2006-06-20 | |
| US88576507P | 2007-01-19 | 2007-01-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080338A1 true PE20080338A1 (es) | 2008-04-25 |
Family
ID=38834248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000768A PE20080338A1 (es) | 2006-06-20 | 2007-06-18 | 4-[5-(2-amino-etansulfonil)-isoquinolin-7-il]-fenol como inhibidor de akt (proteina cinasa) |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7998977B2 (es) |
| EP (1) | EP2035385B1 (es) |
| JP (1) | JP2009541335A (es) |
| KR (1) | KR101067551B1 (es) |
| AR (1) | AR061240A1 (es) |
| AT (1) | ATE455102T1 (es) |
| AU (1) | AU2007261120A1 (es) |
| BR (1) | BRPI0713136A2 (es) |
| CA (1) | CA2652612A1 (es) |
| CL (1) | CL2007001752A1 (es) |
| DE (1) | DE602007004333D1 (es) |
| DK (1) | DK2035385T3 (es) |
| DO (1) | DOP2008000053A (es) |
| EA (1) | EA015712B1 (es) |
| EC (1) | ECSP088992A (es) |
| ES (1) | ES2336630T3 (es) |
| HR (1) | HRP20100147T1 (es) |
| IL (1) | IL195005A0 (es) |
| MA (1) | MA30757B1 (es) |
| MX (1) | MX2008015904A (es) |
| NO (1) | NO20090289L (es) |
| PE (1) | PE20080338A1 (es) |
| PL (1) | PL2035385T3 (es) |
| PT (1) | PT2035385E (es) |
| SI (1) | SI2035385T1 (es) |
| TN (1) | TNSN08529A1 (es) |
| TW (1) | TW200812970A (es) |
| WO (1) | WO2007149730A2 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5856843B2 (ja) | 2008-05-27 | 2016-02-10 | アンピオ ファーマシューティカルズ，インコーポレイテッド | ジケトピペラジンを用いた医薬組成物 |
| EP2613786A4 (en) | 2010-09-07 | 2013-10-23 | Dmi Acquisition Corp | TREATMENT OF DISEASES |
| MY172699A (en) | 2011-10-10 | 2019-12-10 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| EA028343B1 (ru) | 2011-10-10 | 2017-11-30 | Ампио Фармасьютикалз, Инк. | Лечение дегенеративного заболевания сустава |
| EP2771007B1 (en) | 2011-10-28 | 2018-04-04 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
| BR112015020469A2 (pt) | 2013-03-15 | 2020-01-28 | Ampio Pharmaceuticals Inc | Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo |
| CN112472699A (zh) | 2013-07-26 | 2021-03-12 | 种族肿瘤学公司 | 改善比生群及衍生物的治疗益处的组合方法 |
| RU2736513C2 (ru) | 2014-08-18 | 2020-11-17 | Ампио Фармасьютикалз, Инк. | Лечение патологических состояний суставов |
| US10123997B2 (en) * | 2015-06-15 | 2018-11-13 | Yong Liao | Target for treating hepatitis B virus |
| EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES |
| WO2017156350A1 (en) | 2016-03-09 | 2017-09-14 | K-Gen, Inc. | Methods of cancer treatment |
| WO2022017448A1 (zh) * | 2020-07-22 | 2022-01-27 | 南京正大天晴制药有限公司 | 一种二氢吡啶并[2,3-d]嘧啶酮衍生物的盐及晶型 |
| US20230321108A1 (en) * | 2020-07-22 | 2023-10-12 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Unit dosage composition of akt inhibitor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL136458A0 (en) | 2000-05-30 | 2001-06-14 | Peptor Ltd | Protein kinase inhibitors |
| WO2004094386A1 (en) * | 2003-03-28 | 2004-11-04 | Eli Lilly And Company | Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
| GB0317315D0 (en) | 2003-07-24 | 2003-08-27 | Astex Technology Ltd | Pharmaceutical compounds |
| US7449477B2 (en) * | 2003-11-25 | 2008-11-11 | Eli Lilly And Company | 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B) |
-
2007
- 2007-06-06 AR ARP070102429A patent/AR061240A1/es unknown
- 2007-06-12 PL PL07798410T patent/PL2035385T3/pl unknown
- 2007-06-12 JP JP2009516633A patent/JP2009541335A/ja not_active Ceased
- 2007-06-12 BR BRPI0713136-4A patent/BRPI0713136A2/pt not_active IP Right Cessation
- 2007-06-12 MX MX2008015904A patent/MX2008015904A/es active IP Right Grant
- 2007-06-12 EP EP07798410A patent/EP2035385B1/en active Active
- 2007-06-12 ES ES07798410T patent/ES2336630T3/es active Active
- 2007-06-12 EA EA200970041A patent/EA015712B1/ru not_active IP Right Cessation
- 2007-06-12 DK DK07798410.2T patent/DK2035385T3/da active
- 2007-06-12 SI SI200730212T patent/SI2035385T1/sl unknown
- 2007-06-12 KR KR1020087030916A patent/KR101067551B1/ko not_active Expired - Fee Related
- 2007-06-12 AU AU2007261120A patent/AU2007261120A1/en not_active Abandoned
- 2007-06-12 CA CA002652612A patent/CA2652612A1/en not_active Abandoned
- 2007-06-12 WO PCT/US2007/070945 patent/WO2007149730A2/en not_active Ceased
- 2007-06-12 PT PT07798410T patent/PT2035385E/pt unknown
- 2007-06-12 DE DE602007004333T patent/DE602007004333D1/de active Active
- 2007-06-12 AT AT07798410T patent/ATE455102T1/de active
- 2007-06-12 HR HR20100147T patent/HRP20100147T1/hr unknown
- 2007-06-12 US US12/300,358 patent/US7998977B2/en not_active Expired - Fee Related
- 2007-06-15 CL CL2007001752A patent/CL2007001752A1/es unknown
- 2007-06-18 PE PE2007000768A patent/PE20080338A1/es not_active Application Discontinuation
- 2007-06-20 TW TW096122142A patent/TW200812970A/zh unknown
-
2008
- 2008-10-24 DO DO2008000053A patent/DOP2008000053A/es unknown
- 2008-10-30 IL IL195005A patent/IL195005A0/en unknown
- 2008-12-18 EC EC2008008992A patent/ECSP088992A/es unknown
- 2008-12-19 TN TNP2008000529A patent/TNSN08529A1/en unknown
-
2009
- 2009-01-19 NO NO20090289A patent/NO20090289L/no not_active Application Discontinuation
- 2009-01-19 MA MA31573A patent/MA30757B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007149730A2 (en) | 2007-12-27 |
| TNSN08529A1 (en) | 2010-04-14 |
| ECSP088992A (es) | 2009-01-30 |
| CA2652612A1 (en) | 2007-12-27 |
| EP2035385B1 (en) | 2010-01-13 |
| AU2007261120A1 (en) | 2007-12-27 |
| TW200812970A (en) | 2008-03-16 |
| HRP20100147T1 (hr) | 2010-04-30 |
| SI2035385T1 (sl) | 2010-05-31 |
| DOP2008000053A (es) | 2009-01-15 |
| MX2008015904A (es) | 2009-01-12 |
| EA015712B1 (ru) | 2011-10-31 |
| BRPI0713136A2 (pt) | 2012-04-17 |
| AR061240A1 (es) | 2008-08-13 |
| IL195005A0 (en) | 2009-08-03 |
| ATE455102T1 (de) | 2010-01-15 |
| JP2009541335A (ja) | 2009-11-26 |
| ES2336630T3 (es) | 2010-04-14 |
| WO2007149730A3 (en) | 2008-04-24 |
| US20090221633A1 (en) | 2009-09-03 |
| PT2035385E (pt) | 2010-03-01 |
| MA30757B1 (fr) | 2009-10-01 |
| DK2035385T3 (da) | 2010-03-22 |
| CL2007001752A1 (es) | 2008-01-18 |
| US7998977B2 (en) | 2011-08-16 |
| PL2035385T3 (pl) | 2010-06-30 |
| DE602007004333D1 (de) | 2010-03-04 |
| KR20090015978A (ko) | 2009-02-12 |
| KR101067551B1 (ko) | 2011-09-27 |
| EP2035385A2 (en) | 2009-03-18 |
| EA200970041A1 (ru) | 2009-06-30 |
| NO20090289L (no) | 2009-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080338A1 (es) | 4-[5-(2-amino-etansulfonil)-isoquinolin-7-il]-fenol como inhibidor de akt (proteina cinasa) | |
| NO20090878L (no) | Smac peptidoetterligninger nyttige som IAP-inhibitorer | |
| PA8852901A1 (es) | Inhibidores de proteina cinasa | |
| CL2011002761A1 (es) | Compuestos derivados de heterociclos sustituidos, inhibidores del canal romk; composición farmacéutica; y su uso para provocar diuresis, natriuresis o ambas, hipertension, insuficiencia cardiaca, insuficiencia renal aguda y crónica y síndrome nefrótico, entre otras enfermedades. | |
| NI200800175A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de abuso y adicción de sustancias. | |
| CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
| WO2007100895A3 (en) | Cancer treatment with gamma-secretase inhibitors | |
| BRPI0605921B8 (pt) | compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas | |
| EA201100613A1 (ru) | Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций | |
| EA200901617A1 (ru) | Борсодержащие молекулы небольшого размера | |
| CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
| BRPI0821004A8 (pt) | Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste | |
| WO2009156735A3 (en) | New therapeutic agents | |
| CL2007002689A1 (es) | Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras. | |
| CL2009000402A1 (es) | Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras. | |
| UY30158A1 (es) | Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
| EA200801978A1 (ru) | Способ получения и применения фармакологически активного n-карбамоилметил-4(r)-фенил-2-пирролидинона | |
| TW200722421A (en) | Azole derivatives as inhibitors of lipases and phospholipases | |
| PE20151055A1 (es) | Compuestos triciclicos para inhibir el canal cftr | |
| EA201000039A1 (ru) | Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль | |
| AR049274A1 (es) | Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2 | |
| AR058904A1 (es) | Proceso mejorado para la preparacion de un derivado de 5h-pirrolo[3,4-b] pirazina opticamente activo | |
| ECSP088781A (es) | Derivados de benzimidazol | |
| ATE509958T1 (de) | Gegen cathepsin s gerichtete therapie | |
| EA201070194A1 (ru) | Стабильная жидкая фармацевтическая композиция на основе тразодона |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |